Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;37(2):243-247.
doi: 10.1007/s12928-021-00832-0. Epub 2022 Jan 12.

Japanese Nationwide PCI (J-PCI) Registry Annual Report 2019: patient demographics and in-hospital outcomes

Hirohiko Ando  1 , Kyohei Yamaji  2 , Shun Kohsaka  3 , Hideki Ishii  4 , Hideki Wada  5 , Sumio Yamada  6 , Mitsuaki Sawano  7 , Taku Inohara  3 , Yohei Numasawa  8 , Yuji Ikari  9 , Tetsuya Amano  10 ; J-PCI Registry Investigators
Affiliations

Japanese Nationwide PCI (J-PCI) Registry Annual Report 2019: patient demographics and in-hospital outcomes

Hirohiko Ando et al. Cardiovasc Interv Ther. 2022 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

K.Y. reports investigator-initiated grant funding from Abbott. S.K. reports investigator-initiated grant funding from Bayer and Daiichi Sankyo and personal fees from Bristol-Myers Squibb. H.I. receives lecture fees from Astellas, AstraZeneca, Bayer, Bristol-Myers Squibb, Chugai, Daiichi Sankyo, MSD, Otsuka, and Pfizer. T.I. has a research grant from Boston Scientific. T.A. receives lecture fees from Astellas Pharma, AstraZeneca, Bayer, Daiichi Sankyo, and Bristol-Myers Squibb. The rest of the authors have no conflict of interest to report.

Figures

Fig. 1
Fig. 1
Number of registered patients. The annual numbers of patients registered in J-PCI over the past 6 years are shown. J-PCI, The Japanese Percutaneous Coronary Intervention
Fig. 2
Fig. 2
Prevalence of risk factors. The prevalence of risk factors over the past 6 years is shown. CKD, chronic kidney disease; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; HF, heart failure; MI, myocardial infarction; COPD, chronic obstructive pulmonary disease; PAD, peripheral artery disease
Fig. 3
Fig. 3
Number of patients with various clinical presentations. The annual numbers of patients with various clinical presentations over the past 6 years are shown. STEMI, ST-elevation myocardial infarction; NSTEMI, non-ST-elevation myocardial infarction; MI, myocardial infarction; PCI, percutaneous coronary intervention
Fig. 4
Fig. 4
Proportion of radial artery approach. The proportions of PCI with radial artery approach over the past 6 years are shown. Abbreviations as in Fig. 3
Fig. 5
Fig. 5
In-hospital mortality with and without radial artery approach. In-hospital mortality according to various clinical presentations with and without radial artery approach is shown. Abbreviations as in Fig. 3
See this image and copyright information in PMC

References

    1. Sawano M, Yamaji K, Kohsaka S, Inohara T, Numasawa Y, Ando H, et al. Contemporary use and trends in percutaneous coronary intervention in Japan: an outline of the J-PCI registry. Cardiovasc Interv Ther. 2020;35:218–226. doi: 10.1007/s12928-020-00669-z. - DOI - PMC - PubMed
    1. Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K, et al. JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome. Circ J. 2019;83:1085–1196. doi: 10.1253/circj.CJ-19-0133. - DOI - PubMed
    1. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40:87–165. doi: 10.1093/eurheartj/ehy394. - DOI - PubMed
    1. Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Boden WE, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382:1395–1407. doi: 10.1056/NEJMoa1915922. - DOI - PMC - PubMed
    1. Niimi N, Sawano M, Ikemura N, Nagai T, Nakano S, Shoji S, et al. Applicability and eligibility of the international study of comparative health effectiveness with medical and invasive approaches (ISCHEMIA) for patients who underwent revascularization with percutaneous coronary intervention. J Clin Med. 2020;2020:9. doi: 10.3390/jcm9092889. - DOI - PMC - PubMed

LinkOut - more resources